Beyond pharmacology in heart attacks: Coronary stents and stem cells Report uri icon


MeSH Major

  • Antibodies, Monoclonal
  • Neural Networks (Computer)
  • Platelet Aggregation Inhibitors


  • The past two decades have been tremendously exciting for clinicians managing patients suffering myocardial infarction, as we defined our understanding of the proximate cause of the thrombotic occlusion of the infarct-related artery, triggered mostly by a ruptured or fissured coronary plaque, with downstream embolism of thrombotic material and resultant myocardial necrosis. This article summarizes developments in non pharmacological therapy with percutaneous coronary artery stenting of the culprit occlusion, and newer approaches in reparative cardiology via stemcell implantation in the infarcted zone.

publication date

  • November 19, 2007



  • Report

Additional Document Info

start page

  • 19

end page

  • 23


  • 36